Service Delivery

December 2015

New global estimates show that an estimated 357 million new infections of chlamydia, gonorrhoea, syphilis and trichomoniasis occur every year. When calculated with previous estimates of herpes simplex virus and human papillomavirus (HPV) infections, the data suggest that more than one million sexually transmitted infections are acquired every day. Read More

October 2015

August 2015

June 2015

Burden of obstetric fistula

This study estimated the lifetime and point prevalence of symptoms of vaginal fistula in sub-Saharan Africa, region using national household surveys based on self-report of symptoms. Data were drawn from 19 of the most recent Demographic and Health Surveys (DHS) and Multiple Indicators Cluster Surveys (MICS) from sub-Saharan Africa. Read More

May 2015

Menopausal hormone use and ovarian cancer risk – new meta-analysis

This meta-analysis aimed to assess the effects of hormone therapy on ovarian cancer risk, using individual participant data from 52 epidemiological studies assessing hormone therapy use and ovarian cancer risk. The principal analyses involved data from 17 prospective studies that followed up 12,110 postmenopausal women who developed ovarian cancer, 55% of whom had used hormone therapy. The analysis found that there was increased risk with current hormone therapy use, with a relative risk of 1·43 up to five years of hormone replacement therapy use, and 1·41 for five years or longer. Read More

Breast cancer drug, tamoxifen, has 20-year preventive effect

The preventative effect of the breast cancer drug tamoxifen is maintained for 20 years, reducing rates of the disease by about 30%. The study randomly assigned 7,154 premenopausal and postmenopausal women 35–70 years of age, deemed to be at an increased risk of developing breast cancer, between April 1992 and March 2001, to receive oral tamoxifen 20 mg daily or matching placebo for five years. Read More